Javier Carbajo-Lozoya

The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors

Susanne Pfefferle, Julia Schöpf, Manfred Kögl et al. · PLoS Pathogens · 2011 · 430 citations · Full text

Viral Pathogenesis, Immunology, Antiviral Drug +18

p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PL ^pro via E3 ubiquitin ligase RCHY1

Yue Ma‐Lauer, Javier Carbajo-Lozoya, Marco Y. Hein et al. · Proceedings of the National Academy of Sciences · 2016 · 214 citations · Full text

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506

Javier Carbajo-Lozoya, Marcel A. Müller, Stephan Kallies et al. · Virus Research · 2012 · 205 citations · Full text

Medicine, Antiviral Drug Development, Antiviral Therapy +7

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Javier Carbajo-Lozoya, Yue Ma‐Lauer, Miroslav Malešević et al. · Virus Research · 2014 · 139 citations · Full text

Molecular Virology, Pathogenesis, Viral Pathogenesis +9

COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany

Christopher Holzmann‐Littig, Matthias C. Braunisch, Peter Kranke et al. · Vaccines · 2021 · 108 citations · Full text

Vaccination, Vaccine Safety, Preventive Medicine +15